Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
Background: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenance of fetomaternal immuno-privilege state, it has been implicated in tumour tolerance, autoimmune diseases and asthma. IDO is an IFN-γ-inducible, intracellular enzyme that catalyzes the initial and rat...
Main Authors: | Quan, J, Tan, P, MacDonald, A, Friend, P |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2008
|
פריטים דומים
-
Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
מאת: Quan, J, et al.
יצא לאור: (2008) -
The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
מאת: Chiara Suvieri, et al.
יצא לאור: (2024-11-01) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
מאת: V. A. Kozlov, et al.
יצא לאור: (2017-07-01) -
Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
מאת: Cemil Bilir, M.D., et al.
יצא לאור: (2017-07-01) -
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
מאת: Heike Loeser, et al.
יצא לאור: (2020-01-01)